Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Eur J Drug Metab Pharmacokinet ; 33(3): 149-57, 2008.
Artigo em Inglês | MEDLINE | ID: mdl-19007040

RESUMO

Hyaluronic acid (HA), is a high molecular weight (HMW) glucosaminoglycan with significant acitivity, and which influences a number of physiological and pathological processes such as tumorogenesis, arthritis, etc. The aim of this study was to determine the difference in the biodistributional pathways of 111In-labeled diethylenetriaminepentaacetic acid-hyaluronic acid (111In-DTPA-HA) molecule of three different MWs (10, 100 and 450 kDA) in a rat model, and to determine possible relationships between the biodistribution and the MW of the investigated agent for future medical applications. 111In-DTPA-HA was prepared by mixing activated DTPA and activated HA, then adding 111InCl3 to the previously prepared mixture at pH 5,5 in an acetic buffer. Biodistributional studies were performed using 36 male Wistar rats aged 2 months and weighing 280 - 350 g. The radioactivity in the samples was measured via a radiometer and the radioactivity in the different organs, blood, plasma and urine was determined. It was found that 50-54% for 10 and 100 kDa and 80% for 450 kDa of the administered dose of radiolabel was present in the liver after 5 min. Other organs show no significant increase during the experimental period. The elimination of the radiolabel was mostly renal and in low molecular weight (LMW) form. Radioactivity remained in liver throughout the 72h experimental period. A difference in the biodistribution of 450 kDa and LMW radiolabeled molecules was found. Higher amounts of radiolabel were taken up by the liver when the 450 kDa molecule was used. LMW fractions were found in the urine, and could have been a product of non-enzymatic cleavage. The extended retention of radiolabel in the liver could be related to changes in the polarity of DTPA-HA molecules.


Assuntos
Ácido Hialurônico/farmacocinética , Animais , Disponibilidade Biológica , Cromatografia Líquida de Alta Pressão , Composição de Medicamentos , Estabilidade de Medicamentos , Ácido Hialurônico/administração & dosagem , Ácido Hialurônico/química , Radioisótopos de Índio , Injeções Intravenosas , Masculino , Taxa de Depuração Metabólica , Peso Molecular , Ácido Pentético/química , Ratos , Ratos Wistar , Distribuição Tecidual
2.
Ceska Slov Farm ; 56(6): 264-8, 2007 Dec.
Artigo em Tcheco | MEDLINE | ID: mdl-18257416

RESUMO

Hyaluronic acid represents one of the main components of the extracellular matrices. Its physical-chemical and biological properties offer a wide spectrum of use of this molecule, both in industry and medical sciences. The review paper presents our contemporary knowledge gained in the research of hyaluronic acid, describing its principal behaviour in physiological and pathological processes as well as its principal pharmacokinetic and pharmacodynamic properties.


Assuntos
Ácido Hialurônico/farmacologia , Ácido Hialurônico/fisiologia , Humanos
3.
J Pharm Biomed Anal ; 52(4): 517-24, 2010 Aug 01.
Artigo em Inglês | MEDLINE | ID: mdl-20189740

RESUMO

Three different procedures for the labeling of hyaluronan (HA) with (111)In, (125)I and (14)C radionuclides were compared, and the kinetic stability of radiolabeled HA under different conditions (saline, artificial gastric juice and plasma) was established. Modification of HA structure with bifunctional chelating agents (DTPA) or with the prosthetic group (tyramine or tyrosine) was essential prior (111)In and (125)I labeling. These chemical labeling techniques were fast, simple and inexpensive, and labeled agents with a high specific activity were obtained. The only disadvantage of these methods was the occurrence of unknown functional groups in the HA molecule requiring further characterization of the compound. Conversely, HA labeling with (14)C by biotechnological synthesis was found to be rather expensive and time-consuming process. Although, the final product (14)C-HA was identical to natural HA its low specific activity presents certain limitation for its application in biological experiments. Stability studies showed that (14)C-HA and (125)I-Tm-HA were stable in all studied mediums. In the case of (125)I-Trs-HA, stability slightly decreased in rat plasma and in artificial gastric juice with increasing time. The least stable was (111)In-DTPA-HA, which degraded completely after 48h in artificial gastric juice. Kinetic stability studies may provide primary information concerning the properties of radiolabeled HA in vitro, which is essential for the use and explanation of its behavior in biological experiments.


Assuntos
Radioisótopos de Carbono/química , Ácido Hialurônico/síntese química , Radioisótopos de Índio/química , Radioisótopos do Iodo/química , Animais , Radioisótopos de Carbono/farmacocinética , Estabilidade de Medicamentos , Ácido Hialurônico/farmacocinética , Radioisótopos de Índio/farmacocinética , Radioisótopos do Iodo/farmacocinética , Masculino , Ratos , Ratos Wistar
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa